Vaccine, April 18, 2013, Vol.31, p.B157-B162
To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.vaccine.2012.10.113 Byline: Debra Kristensen, Dexiang Chen Keywords: Vaccine; Technology; Formulation; Delivery; Industry; Developing country Abbreviations: AD, autodisable; LIC, low-income country; LMIC, lower-middle-income country; OPV, oral polio vaccine; PDP, product development partnership; R&D, research and development; UNICEF, United Nations Children's Fund; VPPAG, Vaccine Presentation and Packaging Advisory Group; WHO, World Health Organization Abstract: a* Vaccine technologies can improve immunization effectiveness, acceptability, and safety. a* Donor support for vaccine technology development is strong. a* Uptake of proven technologies by the vaccine industry and demand by purchasers continues to lag. a* Article highlights barriers and opportunities from case studies. a* Strategies are proposed to accelerate availability of beneficial vaccine technologies. Author Affiliation: PATH, Seattle, WA 98121, USA
Product Development ; Vaccines ; Public Health
Cengage Learning, Inc.